Computationally predicting clinical drug combination efficacy with cancer cell line screens and independent drug action

Abstract

Computational models that can predict drug combination efficacy are often based on drug synergy. Here, the authors develop a different approach to computationally predict the efficacy of drug combinations using monotherapy data from high-throughput cancer cell line screens.